Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Frequency of germline pathogenic variants in breast cancer predisposing genes in a national cohort of young women with breast cancer.

British journal of cancer·2026

Same author

PCSK9 rs562556 variant and survival in BRCA1 mutation carriers and mutation-negative familial breast cancer.

NPJ breast cancer·2026

Same author

Clinicopathologic characteristics of early-onset breast cancer among unselected young Black women.

Cancer·2026

Same author

Are current Polish guidelines for prophylactic mastectomy sufficient?

Hereditary cancer in clinical practice·2026

Same author

Commentary: Recommendations for a Canadian Breast Implant Registry.

Plastic surgery (Oakville, Ont.)·2026

Same author

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Search research articles

Related Experiment Video

Updated: Feb 24, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Breast Cancer Genetics for Plastic Surgeons.

Niall M McInerney^1,2, Steven Narod^1,2, Kelly Metcalfe^1,2

¹Toronto, Ontario, Canada.

Plastic and Reconstructive Surgery

|August 26, 2017

Summary

Genetic clinics aid familial breast cancer patients. Plastic surgeons play a key role in risk-reducing and reconstructive surgeries, requiring awareness of associated genetic variants.

More Related Videos

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Feb 24, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

Area of Science:

Oncology
Genetics
Plastic Surgery

Background:

Multidisciplinary genetic clinics provide counseling and testing for hereditary breast cancer.
Plastic surgeons are essential for patients undergoing risk-reducing or reconstructive surgery.
Understanding genetic variants is crucial for managing patient care.

Purpose of the Study:

To highlight the importance of plastic surgeons' awareness of genetic variants in familial breast cancer.
To emphasize the role of plastic surgeons in prophylactic and therapeutic surgical decisions.

Main Methods:

Review of current practices in multidisciplinary genetic clinics.
Analysis of the intersection between genetic counseling and plastic surgery for breast cancer patients.

Main Results:

Plastic surgeons are integral to the care pathway for hereditary breast cancer.
Knowledge of specific genetic variants informs surgical risk assessment and planning.

Conclusions:

Plastic surgeons must be informed about genetic risks associated with familial breast cancer.
This awareness enhances patient counseling and surgical outcomes for risk-reducing and reconstructive procedures.